ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

TNYA Tenaya Therapeutics Inc

4,68
0,12 (2,63%)
Nach Börsenschluss
Zuletzt aktualisiert: 23:16:11
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Tenaya Therapeutics Inc TNYA NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,12 2,63% 4,68 23:16:11
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
4,58 4,47 4,81 4,68 4,56
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
18.3.202421:05GLOBETenaya Therapeutics Reports Fourth Quarter and Full Year..
18.3.202413:30GLOBETenaya Therapeutics Announces Publication of TN-401 Gene..
28.2.202401:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:30GLOBETenaya Therapeutics to Participate in Upcoming March..
26.2.202414:30GLOBETenaya Therapeutics Announces Publication of Preclinical..
17.2.202402:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.2.202402:13EDGAR2Form 144 - Report of proposed sale of securities
08.2.202423:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08.2.202414:15EDGAR2Form 8-K - Current report
08.2.202414:00GLOBETenaya Therapeutics Announces Pricing of Underwritten..
31.1.202422:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
03.1.202414:30GLOBETenaya Therapeutics to Participate at the 42nd Annual J.P...
21.11.202322:30GLOBETenaya Therapeutics to Participate at the 35th Annual Piper..
08.11.202322:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.11.202322:12EDGAR2Form 8-K - Current report
08.11.202322:05GLOBETenaya Therapeutics Reports Third Quarter 2023 Financial..
26.10.202314:30GLOBETenaya Therapeutics Announces FDA Clearance to Begin..
09.10.202314:30GLOBETenaya Therapeutics Presents Encouraging New Clinical and..
05.10.202314:30GLOBETenaya Therapeutics Doses First Patient in the MyPeak-1™..
02.10.202323:30GLOBETenaya Therapeutics Publishes Preclinical Data in..
21.9.202322:05GLOBETenaya Therapeutics to Present Data for TN-301 and TN-201 at..
31.8.202322:05GLOBETenaya Therapeutics to Participate at the 21st Annual Morgan..
19.8.202300:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.8.202303:10EDGAR2Form 144 - Report of proposed sale of securities
09.8.202322:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.8.202322:19EDGAR2Form 8-K - Current report
09.8.202322:05GLOBETenaya Therapeutics Reports Second Quarter 2023 Financial..
02.8.202322:05GLOBETenaya Therapeutics to Participate at the 43rd Annual..
10.5.202322:19GLOBETenaya Therapeutics Reports First Quarter 2023 Financial..
03.5.202314:00GLOBETenaya Highlights Growing Capabilities in AAV Manufacturing,..
02.5.202314:43DJNTenaya Therapeutics Gets FDA Fast-Track Designation for..
02.5.202313:50GLOBETenaya Therapeutics Receives FDA Fast Track Designation for..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock